|
US7825121B2
(en)
*
|
1999-05-04 |
2010-11-02 |
Schering Corporation |
Piperazine derivatives useful as CCR5 antagonists
|
|
PL364560A1
(en)
|
2001-03-29 |
2004-12-13 |
Schering Corporation |
Ccr5 antagonists useful for treating aids
|
|
EP1373206B1
(en)
*
|
2001-03-29 |
2008-12-24 |
Schering Corporation |
Aryl oxime-piperazines useful as ccr5 antagonists
|
|
EP1451174B1
(en)
*
|
2001-11-29 |
2010-08-18 |
Schering Corporation |
Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
|
|
EP2311818B1
(en)
|
2002-02-28 |
2013-01-16 |
Novartis AG |
Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug
|
|
JP4671091B2
(ja)
*
|
2002-03-18 |
2011-04-13 |
東レ・ファインケミカル株式会社 |
１−置換−２−メチルピペラジンの製造方法
|
|
EP2141143A3
(en)
|
2002-03-29 |
2010-05-05 |
Schering Corporation |
Stereoselective alkylation of chiral 2-methyl-4 protected piperazines
|
|
CN100396676C
(zh)
*
|
2002-03-29 |
2008-06-25 |
先灵公司 |
作为ccr5拮抗药的哌啶和哌嗪化合物的合成
|
|
CA2483253A1
(en)
*
|
2002-04-24 |
2003-11-06 |
Takeda Pharmaceutical Company Limited |
Use of compounds having ccr antagonism
|
|
JP2003335737A
(ja)
|
2002-05-21 |
2003-11-28 |
Central Glass Co Ltd |
光学活性（ｒ）−１−（４−トリフルオロメチルフェニル）エチルアミン
|
|
TW200504033A
(en)
*
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
|
US20060251651A1
(en)
*
|
2002-12-13 |
2006-11-09 |
Ono Pharmaceutical Co., Ltd. |
Antagonist and agonist which bind to a strong binding site of chemokine receptor
|
|
PE20040769A1
(es)
*
|
2002-12-18 |
2004-11-06 |
Schering Corp |
Derivados de piperidina utiles como antagonisas ccr5
|
|
WO2004080966A1
(ja)
|
2003-03-14 |
2004-09-23 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
|
US7498323B2
(en)
|
2003-04-18 |
2009-03-03 |
Ono Pharmaceuticals Co., Ltd. |
Spiro-piperidine compounds and medicinal use thereof
|
|
US20070043079A1
(en)
*
|
2003-04-18 |
2007-02-22 |
Hiromu Habashita |
Heterocyclic compound containing nitrogen atom and use thereof
|
|
TW200519106A
(en)
|
2003-05-02 |
2005-06-16 |
Novartis Ag |
Organic compounds
|
|
GB0313661D0
(en)
*
|
2003-06-13 |
2003-07-16 |
Avecia Ltd |
Process
|
|
EP1633737A1
(en)
*
|
2003-06-13 |
2006-03-15 |
Schering Aktiengesellschaft |
Quinolyl amide derivatives as ccr-5 antagonists
|
|
MXPA05013596A
(es)
|
2003-06-30 |
2006-03-09 |
Schering Corp |
Antagonistas de hormona concentradora de melanina para el tratamiento de obesidad.
|
|
CN1898231B
(zh)
|
2003-11-03 |
2010-10-27 |
先灵公司 |
用作趋化因子受体抑制剂的双六氢吡啶衍生物
|
|
GB0329284D0
(en)
*
|
2003-12-18 |
2004-01-21 |
Avecia Ltd |
Process
|
|
GB0401334D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
|
EP1725235B1
(en)
*
|
2004-02-05 |
2009-04-15 |
Schering Corporation |
Piperidine derivatives useful as ccr3 antagonists
|
|
KR100863854B1
(ko)
|
2004-02-10 |
2008-10-15 |
에프. 호프만-라 로슈 아게 |
케모카인 ｃｃｒ5 수용체 조절제
|
|
CN101768129B
(zh)
|
2004-03-05 |
2012-05-23 |
日产化学工业株式会社 |
异*唑啉取代苯甲酰胺化合物的制备中间体
|
|
BRPI0509803A
(pt)
*
|
2004-04-13 |
2007-09-18 |
Incyte Corp |
derivados de piperazinilpiperidina como antagonistas de receptor de quimiocina
|
|
RU2006146608A
(ru)
|
2004-06-09 |
2008-07-20 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
ОКТАГИДРОПИРРОЛО[3,4-с]-ПРОИЗВОДНЫЕ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПРОТИВОВИРУСНЫХ АГЕНТОВ
|
|
GB0417804D0
(en)
*
|
2004-08-10 |
2004-09-15 |
Novartis Ag |
Organic compounds
|
|
EP1790637B1
(en)
*
|
2004-09-13 |
2014-01-29 |
Ono Pharmaceutical Co., Ltd. |
Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient
|
|
GT200500281A
(es)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
Compuestos organicos.
|
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
|
CN101115726A
(zh)
|
2004-12-03 |
2008-01-30 |
先灵公司 |
作为cb1拮抗剂的取代哌嗪
|
|
US7880002B2
(en)
|
2004-12-29 |
2011-02-01 |
Millennium Pharmaceuticals, Inc. |
Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
|
|
US7635698B2
(en)
|
2004-12-29 |
2009-12-22 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
AR052865A1
(es)
*
|
2005-01-06 |
2007-04-11 |
Schering Corp |
Preparacion de compuestos farmaceuticos derivados de sales de piperazina
|
|
CN101146793A
(zh)
|
2005-02-16 |
2008-03-19 |
先灵公司 |
具有cxcr3拮抗剂活性的新的杂环取代了的吡啶或苯基化合物
|
|
EP1853583B1
(en)
*
|
2005-02-16 |
2011-09-07 |
Schering Corporation |
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
|
|
CA2598489A1
(en)
*
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Piperazine-piperidines with cxcr3 antagonist activity
|
|
BRPI0607946A2
(pt)
*
|
2005-02-16 |
2009-10-20 |
Schering Corp |
piperazina-piperidinas substituìdas por pirazinila com atividade de antagonista cxcr3
|
|
AU2006214378A1
(en)
*
|
2005-02-16 |
2006-08-24 |
Pharmacopeia, Inc. |
Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
|
|
JP4769257B2
(ja)
*
|
2005-02-23 |
2011-09-07 |
シェーリング コーポレイション |
ケモカインレセプターのインヒビターとして有用なピペリジニルピペラジン誘導体
|
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
US20110052612A1
(en)
|
2005-05-31 |
2011-03-03 |
Ono Pharmaceutical Co., Ltd. |
Spiropiperidine compound and medicinal use thereof
|
|
EP1893603B1
(en)
|
2005-06-02 |
2009-10-14 |
F. Hoffmann-La Roche AG |
Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
|
|
US7665658B2
(en)
|
2005-06-07 |
2010-02-23 |
First Data Corporation |
Dynamic aggregation of payment transactions
|
|
WO2007045573A1
(en)
|
2005-10-19 |
2007-04-26 |
F. Hoffmann-La Roche Ag |
Phenyl-acetamide nnrt inhibitors
|
|
RU2421464C2
(ru)
|
2005-10-21 |
2011-06-20 |
Новартис Аг |
Человеческие антитела к il-13 и их терапевтическое применение
|
|
PT1942108E
(pt)
|
2005-10-28 |
2013-10-24 |
Ono Pharmaceutical Co |
Composto com um grupo básico e a sua utilização
|
|
WO2007058322A1
(ja)
|
2005-11-18 |
2007-05-24 |
Ono Pharmaceutical Co., Ltd. |
塩基性基を含有する化合物およびその用途
|
|
US20070123538A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Schering Corporation |
Compositions comprising a combination of CCR5 and CXCR4 antagonists
|
|
GB0525671D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
AR059021A1
(es)
|
2006-01-18 |
2008-03-05 |
Schering Corp |
Moduladores de receptores cannabinoides
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
KR20090008217A
(ko)
|
2006-03-10 |
2009-01-21 |
오노 야꾸힝 고교 가부시키가이샤 |
질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는 약제
|
|
EP2322525B1
(en)
|
2006-04-21 |
2013-09-18 |
Novartis AG |
Purine derivatives for use as adenosin A2A receptor agonists
|
|
EP2042503B1
(en)
|
2006-05-16 |
2013-01-30 |
Ono Pharmaceutical Co., Ltd. |
Compound having acidic group which may be protected, and use thereof
|
|
WO2008016006A1
(fr)
|
2006-07-31 |
2008-02-07 |
Ono Pharmaceutical Co., Ltd. |
Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
|
|
CA2658984C
(en)
|
2006-08-16 |
2014-12-02 |
Joshua Kennedy-Smith |
Non-nucleoside reverse transcriptase inhibitors
|
|
WO2008037477A1
(en)
|
2006-09-29 |
2008-04-03 |
Novartis Ag |
Pyrazolopyrimidines as p13k lipid kinase inhibitors
|
|
CN101553483B
(zh)
|
2006-12-13 |
2013-04-17 |
弗·哈夫曼-拉罗切有限公司 |
作为非核苷逆转录酶抑制剂的2-(哌啶-4-基)-4-苯氧基-或苯基氨基-嘧啶衍生物
|
|
GB0625523D0
(en)
*
|
2006-12-21 |
2007-01-31 |
Ge Healthcare Ltd |
In vivo imaging agents
|
|
PL2104535T3
(pl)
|
2007-01-10 |
2011-05-31 |
Irm Llc |
Związki i kompozycje jako inhibitory proteazy aktywujące kanały
|
|
PE20090188A1
(es)
|
2007-03-15 |
2009-03-20 |
Novartis Ag |
Compuestos heterociclicos como moduladores de la senda de hedgehog
|
|
JP2010522707A
(ja)
|
2007-03-29 |
2010-07-08 |
エフ．ホフマン−ラ ロシュ アーゲー |
抗ウイルス性複素環化合物
|
|
DE602008005140D1
(de)
|
2007-05-07 |
2011-04-07 |
Novartis Ag |
Organische verbindungen
|
|
CA2687931C
(en)
|
2007-05-31 |
2016-05-24 |
Boehringer Ingelheim International Gmbh |
Ccr2 receptor antagonists and uses thereof
|
|
CN101801952A
(zh)
|
2007-10-01 |
2010-08-11 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr受体拮抗剂的n-杂环联芳基甲酰胺类化合物
|
|
MX2010006421A
(es)
|
2007-12-10 |
2010-06-25 |
Novartis Ag |
Compuestos organicos.
|
|
EP2259772A2
(en)
*
|
2008-02-29 |
2010-12-15 |
Schering Corporation |
Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same
|
|
US8268834B2
(en)
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
WO2009128947A1
(en)
*
|
2008-04-17 |
2009-10-22 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
|
JP2011522860A
(ja)
|
2008-06-10 |
2011-08-04 |
ノバルティス アーゲー |
上皮性ナトリウムチャネルブロッカーとしてのピラジン誘導体
|
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
|
HUE025547T2
(en)
|
2008-12-19 |
2016-02-29 |
Boehringer Ingelheim Int |
Cyclic pyrimidine-4-carboxamides as CCR2 receptor antagonists for the treatment of inflammation, asthma and COPD
|
|
PT2391366E
(pt)
|
2009-01-29 |
2013-02-05 |
Novartis Ag |
Benzimidazoles substituídos para o tratamento de astrocitomas
|
|
WO2010129351A1
(en)
|
2009-04-28 |
2010-11-11 |
Schepens Eye Research Institute |
Method to identify and treat age-related macular degeneration
|
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
|
JP5781510B2
(ja)
|
2009-08-12 |
2015-09-24 |
ノバルティス アーゲー |
ヘテロ環式ヒドラゾン化合物および癌および炎症の処置のためのそれらの使用
|
|
PE20121148A1
(es)
|
2009-08-17 |
2012-09-07 |
Intellikine Llc |
Compuestos heterociclicos y usos de los mismos
|
|
JP5775871B2
(ja)
|
2009-08-20 |
2015-09-09 |
ノバルティス アーゲー |
ヘテロ環式オキシム化合物
|
|
MX2012004792A
(es)
|
2009-10-22 |
2013-02-01 |
Vertex Pharma |
Composiciones para el tratamiento de fibrosis quistica y otras enfermedades cronicas.
|
|
US20130143905A1
(en)
*
|
2009-12-17 |
2013-06-06 |
Boehringer Ingelheim International Gmbh |
Novel antagonists for ccr2 and uses thereof
|
|
ES2674275T3
(es)
|
2009-12-17 |
2018-06-28 |
Centrexion Therapeutics Corporation |
Antagonistas del receptor CCR2 y usos de los mismos
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
EP2569298B1
(en)
|
2010-05-12 |
2015-11-25 |
Boehringer Ingelheim International GmbH |
Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
WO2011141477A1
(en)
|
2010-05-12 |
2011-11-17 |
Boehringer Ingelheim International Gmbh |
New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
WO2011144501A1
(en)
|
2010-05-17 |
2011-11-24 |
Boehringer Ingelheim International Gmbh |
Ccr2 antagonists and uses thereof
|
|
EP2576542B1
(en)
|
2010-05-25 |
2015-04-22 |
Boehringer Ingelheim International GmbH |
Cyclic amide derivatives of pyridazine-3-carboxylic acids and their use in the treatment of pulmonary, pain, immune related and cardiovascular diseases
|
|
EP2576538B1
(en)
|
2010-06-01 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
New CCR2 antagonists
|
|
EP2593452B1
(en)
|
2010-07-14 |
2017-01-18 |
Novartis AG |
Ip receptor agonist heterocyclic compounds
|
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
|
WO2012107500A1
(en)
|
2011-02-10 |
2012-08-16 |
Novartis Ag |
[1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
EP2731941B1
(en)
|
2011-07-15 |
2019-05-08 |
Boehringer Ingelheim International GmbH |
Novel and selective ccr2 antagonists
|
|
EP2741777B1
(en)
|
2011-08-12 |
2017-01-18 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical compositions for treatment of pulmonary hypertension
|
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
|
EA026655B1
(ru)
|
2011-09-15 |
2017-05-31 |
Новартис Аг |
6-ЗАМЕЩЕННЫЕ 3-(ХИНОЛИН-6-ИЛТИО)[1,2,4]ТРИАЗОЛО[4,3-a]ПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ c-MET ТИРОЗИНКИНАЗЫ
|
|
WO2013038381A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine/pyrazine amide derivatives
|
|
WO2013038378A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
CN103946221B
(zh)
|
2011-09-16 |
2016-08-03 |
诺华股份有限公司 |
用于治疗囊性纤维化的杂环化合物
|
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
US9056867B2
(en)
|
2011-09-16 |
2015-06-16 |
Novartis Ag |
N-substituted heterocyclyl carboxamides
|
|
CA2856803A1
(en)
|
2011-11-23 |
2013-05-30 |
Intellikine, Llc |
Enhanced treatment regimens using mtor inhibitors
|
|
US9115129B2
(en)
|
2012-01-13 |
2015-08-25 |
Novartis Ag |
Substituted pyrido[2,3-B]pyrazines as IP receptor agonists
|
|
EP2802582A1
(en)
|
2012-01-13 |
2014-11-19 |
Novartis AG |
Fused dihydropyrido [2,3 -b]pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|
|
ES2561353T3
(es)
|
2012-01-13 |
2016-02-25 |
Novartis Ag |
Sales de un agonista del receptor IP
|
|
EP2802583A1
(en)
|
2012-01-13 |
2014-11-19 |
Novartis AG |
Fused piperidines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|
|
AR089698A1
(es)
|
2012-01-13 |
2014-09-10 |
Novartis Ag |
Compuestos heterociclicos antagonistas del receptor ip
|
|
WO2013105058A1
(en)
|
2012-01-13 |
2013-07-18 |
Novartis Ag |
7,8- dihydropyrido [3, 4 - b] pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|
|
US8809340B2
(en)
|
2012-03-19 |
2014-08-19 |
Novartis Ag |
Crystalline form
|
|
JP2015512425A
(ja)
|
2012-04-03 |
2015-04-27 |
ノバルティス アーゲー |
チロシンキナーゼ阻害剤との組合せ製品及びそれらの使用
|
|
CA2889903C
(en)
|
2012-10-29 |
2021-03-09 |
Manjinder Singh Phull |
Antiviral phosphonate analogues and process for preparation thereof
|
|
ES2637719T3
(es)
|
2013-02-13 |
2017-10-16 |
Novartis Ag |
Compuestos heterocíclicos agonistas del receptor IP
|
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
|
EP2968340A4
(en)
|
2013-03-15 |
2016-08-10 |
Intellikine Llc |
COMBINING KINASE INHIBITORS AND USES THEREOF
|
|
WO2015084804A1
(en)
|
2013-12-03 |
2015-06-11 |
Novartis Ag |
Combination of mdm2 inhibitor and braf inhibitor and their use
|
|
KR20160145780A
(ko)
|
2014-04-24 |
2016-12-20 |
노파르티스 아게 |
포스파티딜이노시톨 3-키나제 억제제로서의 아미노 피리딘 유도체
|
|
EP3134397A1
(en)
|
2014-04-24 |
2017-03-01 |
Novartis AG |
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
|
KR20160141856A
(ko)
|
2014-04-24 |
2016-12-09 |
노파르티스 아게 |
포스파티딜이노시톨 3-키나제 억제제로서의 피라진 유도체
|
|
WO2016011658A1
(en)
|
2014-07-25 |
2016-01-28 |
Novartis Ag |
Combination therapy
|
|
ES2831416T3
(es)
|
2014-07-31 |
2021-06-08 |
Novartis Ag |
Terapia de combinación de un inhibidor de MET y un inhibidor de EGFR
|
|
WO2016028971A1
(en)
*
|
2014-08-21 |
2016-02-25 |
Bristol-Myers Squibb Company |
Tied-back benzamide derivatives as potent rock inhibitors
|
|
MX383744B
(es)
|
2015-07-02 |
2025-03-14 |
Centrexion Therapeutics Corp |
Citrato de (4-((3r,4r)-3-metoxitetrahidro-piran-4-ilamino)piperidin-1-il) (5-metil-6-(((2r, 6s)-6-(p-tolil)tetrahidro-2h-piran-2-il) metilamino) pirimidin-4-il) metanona.
|
|
WO2020250116A1
(en)
|
2019-06-10 |
2020-12-17 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis
|
|
PE20220346A1
(es)
|
2019-08-28 |
2022-03-14 |
Novartis Ag |
Derivados de 1,3-fenil heteroarilo sustituidos y su uso en el tratamiento de enfermedades
|
|
TW202140550A
(zh)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
|
|
US11629196B2
(en)
|
2020-04-27 |
2023-04-18 |
Incelldx, Inc. |
Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
|